Bessemer Group Inc. cut its holdings in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 99.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,588 shares of the company's stock after selling 3,116,262 shares during the quarter. Bessemer Group Inc.'s holdings in ChampionX were worth $342,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in shares of ChampionX by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 19,964,329 shares of the company's stock valued at $542,830,000 after purchasing an additional 227,627 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of ChampionX by 1.4% during the third quarter. Geode Capital Management LLC now owns 4,617,387 shares of the company's stock worth $139,239,000 after buying an additional 63,119 shares in the last quarter. Norges Bank bought a new stake in shares of ChampionX in the fourth quarter valued at about $74,032,000. Charles Schwab Investment Management Inc. increased its position in ChampionX by 2.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,679,414 shares of the company's stock worth $72,853,000 after acquiring an additional 56,283 shares during the period. Finally, Van ECK Associates Corp boosted its holdings in ChampionX by 0.3% in the 4th quarter. Van ECK Associates Corp now owns 2,639,352 shares of the company's stock valued at $71,764,000 after purchasing an additional 9,056 shares during the period. Institutional investors own 98.99% of the company's stock.
ChampionX Stock Performance
Shares of CHX traded down $0.53 during mid-day trading on Monday, hitting $24.88. 286,574 shares of the company's stock were exchanged, compared to its average volume of 2,518,101. The firm has a market cap of $4.75 billion, a price-to-earnings ratio of 15.08 and a beta of 1.81. ChampionX Co. has a 52 week low of $21.92 and a 52 week high of $35.94. The company has a quick ratio of 1.36, a current ratio of 1.99 and a debt-to-equity ratio of 0.32. The stock's 50-day simple moving average is $28.07 and its 200-day simple moving average is $28.93.
ChampionX (NASDAQ:CHX - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.03. ChampionX had a return on equity of 19.84% and a net margin of 8.81%. On average, equities research analysts expect that ChampionX Co. will post 1.92 EPS for the current year.
ChampionX Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, April 4th will be paid a dividend of $0.095 per share. The ex-dividend date is Friday, April 4th. This represents a $0.38 dividend on an annualized basis and a yield of 1.53%. ChampionX's payout ratio is 23.03%.
About ChampionX
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
See Also

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.